The status of carrier of FV(G1691A) mutation was associated with a risk for stroke of 1.98 (95% CI 1.38 to 2.83) and 1.62 (95% CI 1.03 to 2.57), as compared to control subjects and non–PFO–associated stroke patients, respectively. This evidence concerns the gene F5 and stroke disorder.